Nakahata, Tatsutoshi
Central Institute for Experimental Medicine and Life Science,
Japan
2025 Rank: 63,264
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,783 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63,264 | 64,065 |
| Total Cites | 23,387 | 26,695 |
| H-index | 75 | 81 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 24 | 26 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 640 | 746 |
| Number of Single+First+Last Authored Papers | 202 | 202 |
| Total Cites to Single+First+Last Authored Papers | 8,139 | 9,253 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 20,661 | 22,618 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
12.39%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,716 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59,203 | 60,311 |
| Total Cites | 22,418 | 25,622 |
| H-index | 74 | 80 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 24 | 26 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 633 | 739 |
| Number of Single+First+Last Authored Papers | 202 | 202 |
| Total Cites to Single+First+Last Authored Papers | 7,894 | 9,005 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 19,787 | 21,662 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
12.50%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,705 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57,890 | 56,843 |
| Total Cites | 21,502 | 24,634 |
| H-index | 71 | 78 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 23 | 25 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 610 | 722 |
| Number of Single+First+Last Authored Papers | 202 | 202 |
| Total Cites to Single+First+Last Authored Papers | 7,658 | 8,772 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18,967 | 20,789 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
12.71%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,631 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53,320 | 53,753 |
| Total Cites | 20,271 | 23,245 |
| H-index | 69 | 76 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 23 | 25 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 595 | 707 |
| Number of Single+First+Last Authored Papers | 202 | 202 |
| Total Cites to Single+First+Last Authored Papers | 7,329 | 8,425 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17,874 | 19,613 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.19 |
| Self-Citation Percentage |
12.79%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1,588 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51,824 | 51,983 |
| Total Cites | 19,582 | 22,505 |
| H-index | 68 | 75 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 23 | 25 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 580 | 691 |
| Number of Single+First+Last Authored Papers | 202 | 202 |
| Total Cites to Single+First+Last Authored Papers | 7,130 | 8,222 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17,275 | 18,990 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.19 |
| Self-Citation Percentage |
12.99%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1,523 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49,384 | 49,096 |
| Total Cites | 18,234 | 20,967 |
| H-index | 65 | 72 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 21 | 23 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 565 | 676 |
| Number of Single+First+Last Authored Papers | 202 | 202 |
| Total Cites to Single+First+Last Authored Papers | 6,765 | 7,831 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16,061 | 17,666 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.19 |
| Self-Citation Percentage |
13.03%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
Japan5,713 scientists, 10th in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.